CGNX COGNEX CORP
Industrial Instruments For Measurement, Display, and Control · Nasdaq · SEC CIK 851205 · Fiscal year ends 12/31
Financial factors as of 2026-10-04 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY15.8%
TTM net income YoY119.7%
TTM EPS YoY120.0%
Revenue 3-yr CAGR8.5%
Net income 3-yr CAGR15.4%
Margins
Gross margin69.7%
Operating margin25.0%
Net margin21.5%
FCF margin25.4%
EBITDA margin26.7%
Returns
ROE15.1%
ROA11.3%
ROIC (approx.)20.1%
Asset turnover0.53x
Leverage & solvency
Liabilities / assets24.4%
Debt / equity0.00x
Current ratio5.04x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.22x
Accruals ratio-2.5%
Payout ratio23.5%
Capex / revenue0.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $994.36M | $914.51M |
| Cost of revenue | $328.97M | $288.72M |
| Gross profit | $665.39M | $625.79M |
| R&D expense | $138.97M | $139.81M |
| SG&A expense | $363.86M | $370.91M |
| Operating income | $162.57M | $115.06M |
| Pretax income | $182.80M | $131.49M |
| Income tax | $68.36M | $25.32M |
| Net income | $114.44M | $106.17M |
| EBITDA | $182.85M | $136.34M |
| EPS (basic) | 0.68 | 0.62 |
| EPS (diluted) | 0.68 | 0.62 |
| Dividends declared per share | 0.33 | 0.30 |
| Weighted avg. shares (diluted) | 169.37M | 172.61M |
| Balance sheet | ||
| Cash & equivalents | $262.93M | $186.09M |
| Short-term investments | $74.04M | $59.96M |
| Receivables | $146.71M | $143.36M |
| Inventory | $137.89M | $157.53M |
| Current assets | $697.25M | $613.37M |
| PP&E, net | $86.02M | $98.44M |
| Goodwill | $386.28M | $384.94M |
| Intangibles | $81.10M | $90.68M |
| Total assets | $2.02B | $1.99B |
| Current liabilities | $183.55M | $169.38M |
| Total liabilities | $524.65M | $475.35M |
| Shareholders' equity | $1.49B | $1.52B |
| Shares outstanding | 167.00M | 170.43M |
| Cash flow statement | ||
| Operating cash flow | $245.51M | $149.08M |
| Capital expenditure | $8.74M | $15.04M |
| Free cash flow | $236.77M | $134.04M |
| Investing cash flow | $28.02M | -$38.97M |
| Financing cash flow | -$206.69M | -$118.42M |
| Depreciation & amortization | $20.29M | $21.27M |
| Stock-based compensation | $48.52M | $52.44M |
| Dividends paid | $54.63M | $52.33M |
| Share buybacks | $151.23M | $67.08M |
Free plan shows the latest 2 periods; Pro shows all 22 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.